Research Integrity: Difference between revisions

m
m (Date change)
 
(One intermediate revision by the same user not shown)
Line 19: Line 19:
</table>
</table>
<br />
<br />
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[Disclosing Foreign Support and International Activities]] | [[Health Care Vendor Interactions]] | [[Credit Hour Definition]] | [[Whistleblower]]<br />
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[Disclosing Foreign Support and International Activities]] | [[Health Care Vendor Interactions]] | [[Credit Hour Definition]] | [[Whistleblower]] | [[Electronic Digital Signatures and Records]]<br />
<br />
<br />
Policy No.: '''8003'''<br />
Policy No.: '''8003'''<br />
Line 205: Line 205:
==Additional information==
==Additional information==
*Contact the [mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer]<br />
*Contact the [mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer]<br />
*Contact the [mailto:gcyee@unmc.edu Research Integrity Officer]<br />
*Contact the [mailto:jmeza@unmc.edu Research Integrity Officer]<br />




This page maintained by [mailto:dpanowic@unmc.edu dkp].
This page maintained by [mailto:mhurlocker@unmc.edu mh].